New York State Common Retirement Fund
NKTR icon

New York State Common Retirement Fund’s Nektar Therapeutics NKTR Stock Holding History

New York State Common Retirement Fund’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,253
Closed -$12.8K – 3287
2025
Q1 		$12.8K Hold
1,253
– – ﹤0.01% 3049
2024
Q4 		$17.5K Hold
1,253
– – ﹤0.01% 3063
2024
Q3 		$24.4K Sell
1,253
-4,600
-79% -$87.7K ﹤0.01% 3016
2024
Q2 		$109K Buy
+5,853
New +$123K ﹤0.01% 2713
2023
Q3 		– Sell
-86
Closed -$744 – 3337
2023
Q2 		$744 Sell
86
-5,341
-98% -$56.9K ﹤0.01% 3334
2023
Q1 		$57.2K Sell
5,427
-2,260
-29% -$68.4K ﹤0.01% 2963
2022
Q4 		$261K Hold
7,687
– – ﹤0.01% 2611
2022
Q3 		$369K Buy
7,687
+884
+13% +$52.6K ﹤0.01% 2491
2022
Q2 		$388K Sell
6,803
-6,530
-49% -$412K ﹤0.01% 2476
2022
Q1 		$1.08M Sell
13,333
-45
-0.3% -$6.66K ﹤0.01% 2072
2021
Q4 		$2.71M Sell
13,378
-7
-0.1% -$1.52K ﹤0.01% 1616
2021
Q3 		$3.61M Buy
13,385
+52
+0.4% +$12.5K ﹤0.01% 1452
2021
Q2 		$3.43M Buy
13,333
+413
+3% +$114K ﹤0.01% 1530
2021
Q1 		$3.88M Sell
12,920
-2,367
-15% -$737K ﹤0.01% 1400
2020
Q4 		$3.9M Sell
15,287
-1,380
-8% -$357K ﹤0.01% 1351
2020
Q3 		$4.15M Sell
16,667
-2,120
-11% -$667K 0.01% 1233
2020
Q2 		$6.53M Sell
18,787
-720
-4% -$225K 0.01% 1051
2020
Q1 		$5.22M Hold
19,507
– – 0.01% 1043
2019
Q4 		$6.32M Sell
19,507
-666
-3% -$193K 0.01% 1151
2019
Q3 		$5.51M Sell
20,173
-600
-3% -$220K 0.01% 1197
2019
Q2 		$11.1M Buy
20,773
+1,106
+6% +$555K 0.01% 926
2019
Q1 		$9.91M Sell
19,667
-326
-2% -$193K 0.01% 962
2018
Q4 		$9.86M Sell
19,993
-900
-4% -$543K 0.01% 906
2018
Q3 		$19.1M Buy
20,893
+96
+0.5% +$81.9K 0.02% 728
2018
Q2 		$15.2M Buy
20,797
+9,516
+84% +$11M 0.02% 820
2018
Q1 		$18M Sell
11,281
-38
-0.3% -$49K 0.02% 735
2017
Q4 		$10.1M Sell
11,319
-2,632
-19% -$1.56M 0.01% 989
2017
Q3 		$5.02M Sell
13,951
-4,528
-25% -$1.42M 0.01% 1223
2017
Q2 		$5.42M Buy
18,479
+5,090
+38% +$1.47M 0.01% 1236
2017
Q1 		$4.71M Sell
13,389
-62
-0.5% -$13.9K 0.01% 1286
2016
Q4 		$2.48M Buy
13,451
+806
+6% +$164K ﹤0.01% 1580
2016
Q3 		$3.26M Sell
12,645
-91
-0.7% -$23.4K ﹤0.01% 1419
2016
Q2 		$2.72M Buy
12,736
+701
+6% +$157K ﹤0.01% 1493
2016
Q1 		$2.48M Buy
12,035
+227
+2% +$43.6K ﹤0.01% 1490
2015
Q4 		$2.98M Buy
11,808
+220
+2% +$45.2K ﹤0.01% 1442
2015
Q3 		$1.91M Sell
11,588
-682
-6% -$121K ﹤0.01% 1615
2015
Q2 		$2.3M Buy
12,270
+9,015
+277% +$1.55M ﹤0.01% 1790
2015
Q1 		$537K Buy
+3,255
New +$669K ﹤0.01% 2020
2014
Q1 		– Sell
-13,390
Closed -$2.28M – 1981
2013
Q4 		$2.28M Hold
13,390
– – ﹤0.01% 1584
2013
Q3 		$2.1M Buy
+13,390
New +$2.48M ﹤0.01% 1544

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's NKTR Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 1,253 shares — an estimated $12.8K sold.

New York State Common Retirement Fund first reported a position in NKTR in Q3 2013 and held it in 40 quarters. The position peaked at $19.1M in Q3 2018. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,253 Nektar Therapeutics shares in Q2 2025, an estimated $12.8K.
  • New York State Common Retirement Fund first reported a position in Nektar Therapeutics in Q3 2013 and held it in 40 quarters.
  • New York State Common Retirement Fund's Nektar Therapeutics position peaked at $19.1M in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.